Paper39301237
Unveiling multifunctional inhibitors: holistic spectral, electronic and molecular characterization, coupled with biological profiling of substituted pyridine derivatives against LD transpeptidase, heme oxygenase and PPAR gamma.
Begum SY and 7 others. RSC Adv, 2024. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Unveiling multifunctional inhibitors: holistic spectral, electronic and molecular characterization, coupled with biological profiling of substituted pyridine derivatives against LD transpeptidase, heme oxygenase and PPAR gamma. Papers, record 39301237. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39301237
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Unveiling multifunctional inhibitors: holistic spectral, electronic and molecular characterization, coupled with biological profiling of substituted pyridine derivatives against LD transpeptidase, heme oxygenase and PPAR gamma.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38562526 | Physicochemical properties, pharmacokinetic studies, DFT approach, and antioxidant activity of nitro and chloro indolinone derivatives. | Front Chem | 2024 | https://conductscience.org/library/papers/38562526 | PubMed |
| 2 | 38675469 | Unveiling the Potential of Ent-Kaurane Diterpenoids: Multifaceted Natural Products for Drug Discovery. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/38675469 | PubMed |
| 3 | 38522391 | 2,3-Dichloronaphthoquinone derivatives: Synthesis, antimicrobial activity, molecular modelling and ADMET studies. | Bioorg Chem | 2024 | https://conductscience.org/library/papers/38522391 | PubMed |
| 4 | 33550683 | Inhibition of α-glucosidase and α-amylase by herbal compounds for the treatment of type 2 diabetes: A validation of in silico reverse docking with in vitro enzyme assays. | J Diabetes | 2021 | https://conductscience.org/library/papers/33550683 | PubMed |
| 5 | 38500408 | A Comprehensive Examination of Heterocyclic Scaffold Chemistry for Antitubercular Activity. | Chem Biodivers | 2024 | https://conductscience.org/library/papers/38500408 | PubMed |
| 6 | 21128600 | Design, synthesis, and structural analysis of phenylpropanoic acid-type PPARγ-selective agonists: discovery of reversed stereochemistry-activity relationship. | J Med Chem | 2011 | https://conductscience.org/library/papers/21128600 | PubMed |
| 7 | 22162017 | Multiwfn: a multifunctional wavefunction analyzer. | J Comput Chem | 2012 | https://conductscience.org/library/papers/22162017 | PubMed |
| 8 | 33063271 | Ciprofloxacin and moxifloxacin could interact with SARS-CoV-2 protease: preliminary in silico analysis. | Pharmacol Rep | 2020 | https://conductscience.org/library/papers/33063271 | PubMed |
| 9 | 36558921 | Cyclooxygenase-2 (COX-2) as a Target of Anticancer Agents: A Review of Novel Synthesized Scaffolds Having Anticancer and COX-2 Inhibitory Potentialities. | Pharmaceuticals (Basel) | 2022 | https://conductscience.org/library/papers/36558921 | PubMed |
| 10 | 38318567 | Facile Microwave-Assisted Hydrothermal Synthesis of Copper Oxide Nanoneedle Arrays for Practical Biomedical Applications. | Cureus | 2024 | https://conductscience.org/library/papers/38318567 | PubMed |
| 11 | 39062004 | Phytochemical Characterization and Antioxidant Activity Evaluation for Some Plant Extracts in Conjunction with Pharmacological Mechanism Prediction: Insights into Potential Therapeutic Applications in Dyslipidemia and Obesity. | Biomedicines | 2024 | https://conductscience.org/library/papers/39062004 | PubMed |
| 12 | 38792094 | N-Heterocycles as Promising Antiviral Agents: A Comprehensive Overview. | Molecules | 2024 | https://conductscience.org/library/papers/38792094 | PubMed |
| 13 | 37628906 | Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37628906 | PubMed |
| 14 | 35628466 | Pyridine Compounds with Antimicrobial and Antiviral Activities. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35628466 | PubMed |
| 15 | 17534530 | Structure and catalytic mechanism of heme oxygenase. | Nat Prod Rep | 2007 | https://conductscience.org/library/papers/17534530 | PubMed |
| 16 | 31956713 | New thiazole, pyridine and pyrazole derivatives as antioxidant candidates: synthesis, DFT calculations and molecular docking study. | Heliyon | 2020 | https://conductscience.org/library/papers/31956713 | PubMed |
| 17 | 38450660 | In silico design, synthesis and antitubercular activity of novel 2-acylhydrazono-5-arylmethylene-4-thiazolidinones as enoyl-acyl carrier protein reductase inhibitors. | J Biomol Struct Dyn | 2025 | https://conductscience.org/library/papers/38450660 | PubMed |
| 18 | 37005457 | Pyrazole derivatives of pyridine and naphthyridine as proapoptotic agents in cervical and breast cancer cells. | Sci Rep | 2023 | https://conductscience.org/library/papers/37005457 | PubMed |
| 19 | 27820797 | Non-classical transpeptidases yield insight into new antibacterials. | Nat Chem Biol | 2017 | https://conductscience.org/library/papers/27820797 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41407765 | Comprehensive Theoretical, Spectroscopic, Solvent, Topological and Antimicrobial investigation of 5-Chloro-6-fluoro-2-(2-pyrazinyl)-1H-benzimidazole. | Sci Rep | 2025 | https://conductscience.org/library/papers/41407765 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PPARG | 5468 | PubTator's text mining | https://conductscience.org/library/genes/5468 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39301237
GET https://conductscience.org/api/papers/v1/39301237/authors